News
IDIBELL receives funding for four research projects with an international consortium
A total of 709,689€ has been received, and projects will soon begin internationally
New study looks at how mRNAs change during atherosclerosis progression
During the progression of atherosclerosis, significant changes occur in the length of certain mRNAs
Digital tools also generate a strong bond between patients and professionals
It is confirmed that digital tools are able to provide effective emotional support
The ISCIII grants financial aid to 17 IDIBELL health research projects
AES’ grants stimulate biomedical research at IDIBELL once again
New study sets new recommendations for studying TP53 gene linked to hereditary cancer
The importance of a correct interpretation of gene variants is highlighted, since not all of them are hereditary or related to a predisposition to cancer.
IDIBELL’s 8th sLHam fills the auditorium in a magical night to celebrate women in science
The Barradas Auditorium was filled to the last seat to celebrate the International Day of Women and Girls in Science
A light-activated drug to fight psoriasis
The therapeutic efficacy of a new compound against psoriasis is confirmed
The 8th IDIBELL sLHam of scientists will vindicate the role and presence of women in research
The event will take place on Thursday, February 6, at the Barradas Auditorium in L’Hospitalet and will commemorate the International Day of Women and Girls in Science.
A multifaceted look at the role of women in biomedical research will be the focus of this year’s sLHam, which will talk about women as researchers and as researched.
In its 8th edition, the sLHam will have two sessions, a morning session for students and an afternoon session for the general public.
New investment in the research against Ewing’s sarcoma
Aptadel Therapeutics receives half a million dollars for a preclinical research program against Ewing’s sarcoma.